source

NEXTGEN DIGITAL CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT OF UNITS

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – November 07, 2025 18:46 ET  |…

4 months ago

Photonic Inc. Advances to Stage B of DARPAs Quantum Benchmarking Initiative

The company’s unique qubit modality and architecture successfully met Stage A requirements, positioning Photonic for the next phase of validation…

4 months ago

Lakeside Software Expands Global Footprint with New SysTrack Cloud Region in Azure India

New region enhances performance, data residency, and scalability for enterprise IT teams in India and beyond November 05, 2025 23:30…

4 months ago

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…

4 months ago

Virtune launches Virtune Stablecoin Index ETP on Nasdaq Stockholm, Nasdaq Helsinki and Deutsche Brse Xetra

November 05, 2025 03:49 ET  | Source: Virtune AB (Publ) Stockholm, November 5, 2025 – Virtune, a Swedish regulated crypto…

4 months ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

4 months ago

Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin

October 31, 2025 17:00 ET  | Source: Lucas GC Limited NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC…

4 months ago

AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025

October 31, 2025 16:33 ET  | Source: AMSC AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC® (NASDAQ: AMSC), a…

4 months ago

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol…

4 months ago